The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants
Katrina Tatton‐Brown(St George’s University Hospitals NHS Foundation Trust), Valérie Cormier‐Daire(Hôpital Necker-Enfants Malades), Mieke C. Bouma, Anatália Labilloy(Cincinnati Children's Hospital Medical Center), Agnete Jørgensen(University Hospital of North Norway), Blanca Gener(Hospital de Cruces), Laura Yates(Newcastle upon Tyne Hospitals NHS Foundation Trust), I. Karen Temple(University of Southampton), Carlos E. Prada(Cincinnati Children's Hospital Medical Center), Jeroen Breckpot(KU Leuven), Mohnish Suri(Nottingham University Hospitals NHS Trust), David A. Koolen(Radboud University Nijmegen), Peter D. Turnpenny(University of Exeter), Tessa Homfray(University of London), Keri Ramsey(Translational Genomics Research Institute), Moira Blyth(Chapel Allerton Hospital), Vinod Varghese(University Hospital of Wales), Carlo Marcelis(Radboud University Nijmegen), Melissa Lees(Great Ormond Street Hospital), Diana Baralle(Princess Anne Hospital), Deborah Shears(Oxford University Hospitals NHS Trust), Angelo Selicorni(Fondazione Roma), Lionel Van Maldergem, Naomi Yachelevich(New York City Health and Hospitals Corporation), Renata Posmyk(Medical University of Białystok), Beau Crabb, Ajith Kumar(Great Ormond Street Hospital), Cathy Kirally-Borri(Government of Western Australia Department of Health), Cyril Mignot(Sorbonne Université), Lise Aksglæde(Copenhagen University Hospital), Ruth Newbury‐Ecob(University Hospitals Bristol NHS Foundation Trust), Chey Loveday(Institute of Cancer Research), Sarina G. Kant(Erasmus MC), Daniela Q.C.M. Barge‐Schaapveld(Leiden University), Christine Fauth, Shazia Mahamdallie(Institute of Cancer Research), Hermine E. Veenstra‐Knol(University Medical Center Groningen), Katherine Neas(Northwell Health), Kathryn Miller(Albany Medical Center Hospital), Anthony Renwick(Institute of Cancer Research), David Goudie(Ninewells Hospital), Matthew Hunter(Monash Health), Catherine Mercer, Linda M. Randolph(University of Southern California), Richard Fisher(James Cook University Hospital), Tabib Dabir(Belfast Health and Social Care Trust), Anna Zachariou(University of British Columbia), Daniela T. Pilz(University Hospital of Wales)
Cited by 114
Related Papers
Cerebral organoids model human brain development and microcephaly
|Nature|2013|5.4k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Nosology and classification of genetic skeletal disorders: 2010 revision
|American Journal of Medical Genetics Part A|2011|717